Congenital factor VII deficiency

British Journal of Anaesthesia

Volumn 104, Issue 2, 2010, Pages 267-268

  Mandhyan, R ^a   Tiwari, A ^a   Cherian, G ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 7; METHYLDOPA; RECOMBINANT BLOOD CLOTTING FACTOR 7A; SUXAMETHONIUM; THIOPENTAL;

ADULT; ANAMNESIS; ARTERIAL PRESSURE; BLEEDING; BLOOD CLOTTING FACTOR 7 DEFICIENCY; BODY WEIGHT; CASE REPORT; CONGENITAL MALFORMATION; CRYSTALLOID; ENDOTRACHEAL INTUBATION; FEMALE; GENERAL ANESTHESIA; GESTATIONAL AGE; HUMAN; LABORATORY TEST; LETTER; MUSCLE RELAXATION; PRIORITY JOURNAL; RISK FACTOR;

EID: 76749161541     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aep389     Document Type: Letter

References (5)

1. Laws HJ, Harbrecht U, Kö ster B. Hereditary heterozygote factor VII deficiency. Klin Padiatr 1992; 204: 453-454
2. Giansily-Blaizot M, Schved JF. Potential predictors of bleeding risk in inherited factor VII deficiency-clinical, biological and molecular criteria. Thromb Hemost 2005; 94: 899-900
3. Hedner U. Recombinant activated factor VII as a universal haemostatic agent. Blood Coagul Fibrinol 1998; 9(Suppl 1): S147-52
4. Pang G, Donaldson A. Probable right atrial thrombus immediately after recombinant activated factor VII administration. Br J Anaesth 2007; 99: 221-225
5. Ahonen J, Jokela R. Recombinant factor VIIa for life-threatening post-partum haemorrhage. Br J Anaesth 2005; 94: 592-595